J&J Covid-19 Vaccine

Regional News • Americas • Brazil
Brazilian Government decides to buy Pfizer and Janssen Covid-19 vaccines
Meeting between the Brazilian Ministry of Health and Janssen
Meeting between the Brazilian Ministry of Health and Janssen Credit: Ministério da Saúde

The Brazilian Ministry of Health decided on Wednesday to sign contracts for the purchase of vaccines against Covid-19 from Pfizer and Janssen laboratories. The contracts are being drafted and must be signed by the beginning of next week, with a determination of the quantity of doses to be delivered.

The country is experiencing the most serious moment of the pandemic, with reports of collapse in the health system in different states and successive records of deaths by Covid-19, which has increased criticism of the folder for the delay in negotiations to obtain vaccines against the disease.

Business • Health Care
Merck to help produce Johnson & Johnson Covid-19 vaccine
Merck to help produce Johnson & Johnson Covid-19 vaccine
Credit: Montgomery County Planning Commission, via Wikimedia Commons (Creative Commons Attribution 2.0)

Merck, an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world, will help produce Johnson & Johnson's one-shot Covid-19 vaccine, the company announced in a statement.

"Merck [...] announced today it has entered into multiple agreements to support efforts to expand manufacturing capacity and supply of SARS-CoV-2/COVID-19 medicines and vaccines," and will "support the manufacturing and supply of Johnson & Johnson’s SARS-CoV-2/COVID-19 vaccine," the statement reads.

“We are steadfast in our commitment to contribute to the global response to the pandemic as part of the remarkable efforts of the entire medical and scientific community,” said Mike Nally, executive vice president, Human Health at Merck. “This funding from BARDA will allow us to accelerate our efforts to scale up our manufacturing capacity to enable timely delivery of much-needed medicines and vaccines for the pandemic.”

Regional News • Americas • United States
FDA grants emergency approval for Johnson & Johnson Covid-19 vaccine
FDA grants emergency approval for Johnson & Johnson Covid-19 vaccine
Credit: Illustration: Pendect, Ashley Winkler.

The US Food and Drug Administration (FDA) granted emergency approval for the preparation on Saturday (local time). US President Joe Biden spoke of "inspiring news for all Americans and an encouraging development in our efforts to end the crisis". There is "light at the end of the tunnel", but no reason to sound the all-clear, he warned on Saturday evening (local time).

Regional News • Americas • United States
Johnson & Johnson's single-dose Covid-19 vaccine provides protection against severe infections
Johnson & Johnson's single-dose Covid-19 vaccine provides protection against severe infections

The United States Food and Drug Administration could grant emergency use authorization to Johnson & Johnson's single-dose Covid-19 vaccine as early as Saturday, bringing a third vaccine manufacturer to the United States. J&J submitted Covid vaccine data shows a 66% effectiveness overall (72% in the United States and 64% in South Africa) and prevents 100% of hospitalizations and deaths.

Regional News • Europe
Johnson & Johnson applies for EU approval of its Covid-19 vaccine
Johnson & Johnson applies for EU approval of its Covid-19 vaccine
Credit: Raysonho @ Open Grid Scheduler / Grid Engine, CC0, via Wikimedia Commons

The European Medicines Agency (EMA) has stated it has received an application for approval of the Johnson & Johnson Covid-19 vaccine and a decision is expected by mid-March.

Health
J&J CEO: Mutations may lead to annual Covid-19 vaccine shots
J&J CEO: Mutations may lead to annual Covid-19 vaccine shots
Credit: unsplash/Steven Cornfield

Regular Covid-19 shots might be here to stay. Alex Gorsky, CEO of Johnson & Johnson, told CNBC that mutations may lead to a need for annual Covid-19 shots similar to flu shots.

“Unfortunately, as (the virus) spreads it can also mutate,” he said in an interview. “Every time it mutates, it’s almost like another click of the dial so to speak where we can see another variant, another mutation that can have an impact on its ability to fend off antibodies or to have a different kind of response not only to a therapeutic but also to a vaccine.”